Skip to main content

Fagron shareholders approve majority voting items

Written by Customer Service on . Posted in Public Companies.

Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 8 May 2023 – 7 PM CET

Fagron shareholders approve majority voting items

Today, Fagron, the leading global player in pharmaceutical compounding, held its annual general meeting of shareholders. The meeting approved the voting items, with the exemption of the proposal to approve the accelerated vesting in case of a public offer on or a change of control over Fagron as provided for in the Performance Share Plan (agenda item 10). This provision will be deleted from the plan.

Resolutions
The meeting approved, amongst other things, Fagron’s annual financial statements and dividend proposal of €0.25 for the fiscal year 2022, and the remuneration policy. The meeting also approved the proposed appointments.

Composition Board of Directors
Following the approved appointments and the stepping down of Management Deprez BV, represented by Veerle Deprez, the Board of Directors currently consists of the following 8 members: AHOK BV, represented by Mr. Koen Hoffman (chair), Rafael Padilla (CEO), Karin de Jong (CFO), Ann Desender, Els Vandecandelaere LLC, represented by Els Vandecandelaere, Robert ten Hoedt, Neeraj Sharma, and Klaus Röhrig.

Meeting and meeting documents
All meeting documents related to the annual general meeting can be found on the Fagron website. The minutes of the meeting will also be made available on the website.

Dividend calendar
The dividend calendar is as follows:

  • Ex-dividend date: 15 May 2023
  • Record date: 16 May 2023
  • Payment date: 17 May 2023

Further information
Karen Berg
Global Investor Relations Manager
Tel. +31 6 53 44 91 99
karen.berg@fagron.com 

About Fagron
Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 30 countries around the world.

Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails. 

Please open the link below for the press release:
Fagron shareholders approve majority voting items

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.